Healthcare Roundup – Slow turnaround times plague COVID-19 test sites, EU in talks with Moderna and others for COVID-19 vaccine supply Life Science
Healthcare Roundup – $75B to fix “flawed” U.S. COVID-19 testing, J&J on go with early-stage study of COVID-19 vaccine candidate Life Science
Healthcare Roundup – More positive news on the COVID-19 vaccine front, Oxford vaccine produces “double defence” against SARS-CoV-2 Life Science
Healthcare Roundup – Moderna coronavirus vaccine induces immune response, Osmotica completes round trip after FDA nod-stoked rally Life Science
Healthcare Roundup – Vaccine production to begin this summer, Innovation Pharma to commence Brilacidin clinical trials against SARS-CoV-2 Life Science
Healthcare Roundup – Pfizer pledges $100M to fund for new antibiotics, Pressure builds on J&J to halt global talc sales Life Science
Healthcare Roundup – Gilead launches early-stage study of inhaled remdesivir, Mask stocks rally after New Jersey takes action Life Science
Healthcare Roundup – Lysol use approved by EPA against COVID-19, Glaxo teams up with Medicago Life Science
Healthcare Roundup – Unum Therapeutics completes Kiq buy, Becton, Dickinson launches COVID-19 rapid test in U.S. Life Science
Healthcare Roundup – FDA OKs ViiV Healthcare’s fostemsavir, UNITY Biotechnology announces upcoming catalysts for its lead programs Life Science
Healthcare Roundup – Regeneron, Sanofi dip, Fauci says don’t ‘balance lives against the economy’ Life Science
Healthcare Roundup – T2 Biosystems launches COVID-19 molecular diagnostic test, CytoDyn down 32% Life Science
Healthcare Roundup – Gilead prices remdesivir at $390 per vial, RedHill Biopharma to launch late-stage study of opaganib in COVID-19 Life Science
